Trial Profile
Effect of dapagliflozin on nighttime blood pressure in type 2 diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 23 Sep 2023 Status changed from recruiting to discontinued.
- 30 Aug 2019 Status changed from not yet recruiting to recruiting.
- 30 Nov 2018 New trial record